SBRT and Hormone Therapy May Delay Advanced Prostate Cancer Progression

Stereotactic body radiotherapy and hormone treatment resulted in 40.1% 12-month progression-free survival in a recent study.

Related Keywords

United Kingdom ,London ,City Of , ,Institute Of Cancer Research ,National Cancer Institute ,European Society For Radiotherapy ,Alison Tree ,Royal Marsden ,Cancer Research ,European Society ,Honorary Reader ,Chief Investigator ,